OBEX, CO. – Trademark Portfolio
Entity Type: 03
OBEX, CO. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 2 (Paints) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ARX, OBEX, CS2000, CRETESEAL, and CRETESHIELD. The owner is based in LAS VEGAS, NV.
3064 SILVER SAGE DRIVE, SUITE 150
LAS VEGAS, NV 89701
Showing of trademarks Trademarks
Trademark Classifications
OBEX, CO.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Building materials (non-metallic); non-metallic rigid pipes for building
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does OBEX, CO. have?
OBEX, CO. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 cancelled.
What trademark classes does OBEX, CO. file in?
OBEX, CO. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 2 (Paints), Class 19 (Building Materials), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are OBEX, CO.'s most well-known trademarks?
OBEX, CO.'s registered trademark portfolio includes well-known marks such as ARX, OBEX, CS2000, CRETESEAL, and CRETESHIELD. These are among 7 currently registered trademarks in the portfolio.
What is OBEX, CO.'s trademark registration success rate?
OBEX, CO. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.